MooreTJPsatyBMFurbergCD. Time to act on drug safety [see comments]. JAMA1998; 279: 1571–3.
2.
CullenDJBatesDWSmallSDCooperJBNemeskalARLeapeLL. The incident reporting system does not detect adverse drug events: A problem for quality improvement. Jt Comm J Qual Improv1995; 21: 541–8.
3.
BatesDW. Drugs and adverse drug reactions: How worried should we be?JAMA1998;279: 1216–7.
4.
DickinsonJG. FDA seeks to double effort on confusing drug names. Dickinson's FDA Review2000; 7(3):13–4.
5.
CohenJS. Erythromelalgia: New theories and new therapies. J Am Acad Dermatol2000; 43 (5 pt. 1):841–7.
